Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

3
results for

"Cystatin C"

Article category

Keywords

Publication year

"Cystatin C"

Review

Liver fibrosis, cirrhosis, and portal hypertension

Current knowledge about biomarkers of acute kidney injury in liver cirrhosis
Han Ah Lee, Yeon Seok Seo
Clin Mol Hepatol 2022;28(1):31-46.
Published online August 2, 2021
DOI: https://doi.org/10.3350/cmh.2021.0148
Acute kidney injury (AKI) is common in advanced cirrhosis. Prerenal azotemia, hepatorenal syndrome, and acute tubular necrosis are the main causes of AKI in patients with cirrhosis. Evaluation of renal function and differentiation between functional and structural kidney injury are important issues in the management of cirrhosis. However, AKI in cirrhosis exists as a complex clinical spectrum rather than concrete clinical entity. Based on current evidence, changes in serum creatinine (Cr) levels remain the most appropriate standard for defining AKI in cirrhosis. However, serum Cr has a limited role in assessing renal function in this population. This review examines previous studies that investigated the ability of recent biomarkers for AKI in cirrhosis from the perspective of earlier and accurate diagnosis, classification of AKI phenotype, and prediction of clinical outcomes. Serum cystatin C and urine neutrophil gelatinase-associated lipocalin have been extensively studied in cirrhosis, and have facilitated improved diagnosis and prognosis prediction in patients with AKI. In addition, urine N-acetyl-β-D-glucosaminidase, interleukin 18, and kidney injury molecule 1 are other promising biomarkers for advanced cirrhosis. However, the clinical significance of these markers remains unclear because there are no cut-off values defining the normal range and differentiating phenotypes of AKI. In addition, AKI has been defined in terms of serum Cr, and renal biopsy—the gold standard—has not been carried out in most studies. Further discovery of innovate biomarkers and incorporation of various markers could improve the diagnosis and prognosis prediction of AKI, and will translate into meaningful improvements in patient outcomes.

Citations

Citations to this article as recorded by  Crossref logo
  • Evaluation of Acute Kidney Injury (AKI) Biomarkers FABP1, NGAL, Cystatin C and IL-18 in an Indian Cohort of Hospitalized Acute-on-chronic Liver Failure (ACLF) Patients
    Rohini Saha, Samriddhi Sharma, Antara Mondal, Hem C. Sati, Maroof A. Khan, Sandeep Mahajan, Sudip Datta, Shalimar, Pragyan Acharya
    Journal of Clinical and Experimental Hepatology.2025; 15(3): 102491.     CrossRef
  • The efficacy of novel biomarkers for the early detection and management of acute kidney injury: A systematic review
    Mohammed Yousef Almulhim, Gianpaolo Reboldi
    PLOS ONE.2025; 20(1): e0311755.     CrossRef
  • Neutrophil gelatinase–associated lipocalin for predicting acute kidney injury in orthotopic liver transplantation: a systematic review and meta-analysis
    Fangran Yan, Zenghua Zhou, Xueke Du, Sheng He, Linghui Pan
    European Journal of Gastroenterology & Hepatology.2025; 37(6): 683.     CrossRef
  • Understanding acute kidney injury in cirrhosis: Current perspective
    Sayan Malakar, Sumit Rungta, Arghya Samanta, Umair Shamsul Hoda, Piyush Mishra, Gaurav Pande, Akash Roy, Suprabhat Giri, Praveer Rai, Samir Mohindra, Uday C Ghoshal
    World Journal of Hepatology.2025;[Epub]     CrossRef
  • Protective effects of Katsuwonus pelamis hydrolysates against renal injury: Val-Lys as a potent renoprotective peptide
    Ying Cheng, Mingjie Zhou, Zishan Hong, Lin Zheng, Mouming Zhao
    Food & Function.2025; 16(13): 5616.     CrossRef
  • Acute Kidney Injury in Patients with Liver Cirrhosis: From Past to Present Definition and Diagnosis
    Andreea Lungu, Georgiana-Elena Sarbu, Alexandru Sebastian Cotlet, Ilie-Andreas Savin, Ioana-Roxana Damian, Simona Juncu, Cristina Muzica, Irina Girleanu, Ana-Maria Sîngeap, Carol Stanciu, Anca Trifan, Camelia Cojocariu
    Life.2025; 15(8): 1249.     CrossRef
  • The Value of Diffusion Kurtosis Imaging to Assess Liver and Kidney Recovery after Mesenchymal Stem Cell Intervention in CCl4-Induced Cirrhotic Rats
    Jiaming Qin, Shuangshuang Xie, Yongquan Yu, Cheng Zhang, Yumeng Zhao, Dan Tong, Zhandong Hu, Jinxia Zhu, Wen Shen
    American Journal of Nephrology.2025; 56(4): 475.     CrossRef
  • CIRROSE HEPÁTICA EM ESTÁGIO AVANÇADO E O PAPEL DO TRANSPLANTE DE FÍGADO: DESAFIOS ATUAIS E PERSPECTIVAS FUTURAS NO MANEJO DE PACIENTES COM DOENÇA HEPÁTICA TERMINAL
    Gabriel Duarte do Nascimento, Gustavo Ribeiro Mesquita, Gilson Augusto Nunes Martins Pombeiro
    Revista Contemporânea.2025; 5(8): e8869.     CrossRef
  • Nationwide analysis of renal outcomes in chronic hepatitis B patients treated with Tenofovir Alafenamide vs. Entecavir
    Hyuk Kim, Jae Young Kim, Hye-Jin Yoo, Log Young Kim, Jeong-Ju Yoo, Sang Gyune Kim, Young-Seok Kim
    Scientific Reports.2025;[Epub]     CrossRef
  • Association between the C-reactive protein–triglyceride–glucose index (CTI) and the risk of acute kidney injury in critically ill patients with cirrhosis
    Lu-Huai Feng, Tianbao Liao, Tingting Su, Xuefei Zhou, Yang Lu, Lina Huang, Zhenhua Yang
    BMC Nephrology.2025;[Epub]     CrossRef
  • Delhi Model: A New Tool for Predicting Response to Terlipressin in Hepatorenal Syndrome—Acute Kidney Injury
    Jatin Agrawal, Ashish Kumar, Praveen Sharma, Naresh Bansal, Vikas Singla, Samarth Sharma, Anil Arora
    Journal of Clinical and Experimental Hepatology.2024; 14(1): 101266.     CrossRef
  • Fibrotic Burden in Patients With Hepatitis B Virus–Related Cirrhosis Is Independently Associated With Poorer Kidney Outcomes
    Chan-Young Jung, Hui-Yun Jung, Hyung Woo Kim, Geun Woo Ryu, Jung Il Lee, Sang Hoon Ahn, Seung Up Kim, Beom Seok Kim
    The Journal of Infectious Diseases.2024; 229(1): 108.     CrossRef
  • VWF/ADAMTS13 Ratio as a Potential Predictive Biomarker for Acute Kidney Injury Onset in Cirrhosis
    Shohei Asada, Tadashi Namisaki, Kosuke Kaji, Hiroaki Takaya, Takahiro Kubo, Takemi Akahane, Hideto Kawaratani, Norihisa Nishimura, Soichi Takeda, Hiroyuki Masuda, Akihiko Shibamoto, Takashi Inoue, Satoshi Iwai, Fumimasa Tomooka, Yuki Tsuji, Yukihisa Fujin
    Digestive Diseases and Sciences.2024; 69(3): 851.     CrossRef
  • Evaluation of Kidney Injury Using Arterial Spin Labeling and Blood Oxygen Level‐Dependent MRI: An Experimental Study in Rats With Carbon Tetrachloride‐Induced Liver Cirrhosis
    Jiaming Qin, Shuangshuang Xie, Yongquan Yu, Jiaqi Yang, Yumeng Zhao, Caixin Qiu, Xiaotian Li, Cheng Zhang, Zhandong Hu, Dan Tong, Jinxia Zhu, Bernd Kuehn, Wen Shen
    Journal of Magnetic Resonance Imaging.2024;[Epub]     CrossRef
  • Features of the course of hepatorenal syndrome in decompensated portal hypertension (case report)
    M.I. Tutchenko, D.V. Rudyk, M.S. Besedinskyi, S.L. Chub, Yu.V. Nerushchenko
    GASTROENTEROLOGY.2024; 58(2): 151.     CrossRef
  • Development and validation of a web-based nomogram for acute kidney injury in acute non-variceal upper gastrointestinal bleeding patients
    Chaolian Wei, Honghua Cao, Lina Huang, Lu-Huai Feng
    Frontiers in Medicine.2024;[Epub]     CrossRef
  • Can Novel Biomarkers Effectively Predict Acute Kidney Injury in Liver or Kidney Transplant Recipients?
    Hubert Zywno, Wojciech Figiel, Michal Grat, Slawomir Nazarewski, Zbigniew Galazka, Jolanta Malyszko
    International Journal of Molecular Sciences.2024; 25(22): 12072.     CrossRef
  • Novel biomarkers of acute kidney injury in chronic liver disease: Where do we stand after a decade of research?
    Rohan Vijay Yewale, Balakrishnan Siddartha Ramakrishna
    Hepatology Research.2023; 53(1): 3.     CrossRef
  • Medication dosing in adult patients with reduced lean body mass and kidney injury: A focus on cystatin C
    Brian L Erstad, David E Nix
    American Journal of Health-System Pharmacy.2023; 80(12): 712.     CrossRef
  • Acute kidney injury in patients with acute-on-chronic liver failure: clinical significance and management
    Jeong-Ju Yoo, Moo Yong Park, Sang Gyune Kim
    Kidney Research and Clinical Practice.2023; 42(3): 286.     CrossRef
  • Urinary N-Acetyl-Beta-D-Glucosaminidase levels predict immunoglobulin a nephropathy remission status
    Xiao Liu, Shaomin Gong, Yichun Ning, Yang Li, Huili Zhou, Luna He, Lin Lin, Shi Jin, Ziyan Shen, Bowen Zhu, Fang Li, Jie Li, Xiao Tan, Xiaoyan Jiao, Yiqin Shi, Xiaoqiang Ding
    BMC Nephrology.2023;[Epub]     CrossRef
  • Hepatorenal syndrome: Current concepts and future perspectives
    Chan-Young Jung, Jai Won Chang
    Clinical and Molecular Hepatology.2023; 29(4): 891.     CrossRef
  • Diagnostic value of combined detection of urine NGAL, KIM-1, and TFF3 in acute tubular necrosis associated with cirrhosis
    Yan-Qing Gong, Ying Zhao, Yan-Hui Jia, Man Li, Yong Jiang
    World Chinese Journal of Digestology.2023; 31(19): 808.     CrossRef
  • Influence of fluid balance on postoperative outcomes after hepatic resection in patients with left ventricular diastolic dysfunction
    Jungho Shin, Suk-Won Suh
    Frontiers in Surgery.2022;[Epub]     CrossRef
  • Urinary neutrophil gelatinase-associated lipocalin: Acute kidney injury in liver cirrhosis
    Pooja Basthi Mohan, Shankar Prasad Nagaraju, Dharshan Rangaswamy, Balaji Musunuri, Ravindra Prabhu Attur, Ganesh Bhat, Shailesh, Shiran Shetty
    Clinica Chimica Acta.2021; 523: 339.     CrossRef
  • 11,890 View
  • 365 Download
  • 24 Web of Science
  • Crossref
Original Articles
Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels
Dong Jin Kim, Hyun Seok Kang, Hyuk Soon Choi, Hye Jin Cho, Eun Sun Kim, Bora Keum, Hyonggin An, Ji Hoon Kim, Yeon Seok Seo, Yong Sik Kim, Hyung Joon Yim, Yoon Tae Jeen, Hong Sik Lee, Soon Ho Um, Chang Duck Kim, Ho Sang Ryu
Korean J Hepatol 2011;17(2):130-138.
Published online June 23, 2011
DOI: https://doi.org/10.3350/kjhep.2011.17.2.130
Background/Aims

Several studies suggested that serum cystatin C (CysC) is more useful than serum creatinine (Cr) for the assessment of renal function in patients with liver cirrhosis. This study evaluated the clinical significance of CysC in patients with cirrhotic ascites and normal Cr level.

Methods

We enrolled patients with cirrhotic ascites and a normal serum Cr level (<1.2 mg/dL). GFR was measured by 99mTc-DTPA renal scan. Serum Cr, CysC, and Cr clearance (CCr) were measured on the same day. Significant renal impairment and severe renal impairment were defined as GFR <60 mL/min and GFR <30 mL/min, respectively.

Results

Eighty-nine patients with cirrhotic ascites were enrolled in the study (63 men and 26 women; age, 55±11 years). Forty-seven (52.8%) and 42 (47.2%) patients were in Child-Pugh grade B and C, respectively. Serum Cr and CysC levels and GFR were 0.8±0.2 mg/dL, 1.1±0.3 mg/L, and 73.4±25.5 mL/min, respectively. Significant and severe renal impairment were noted in 28 (31.5%) and 2 (2.2%) patients, respectively. GFR was well correlated with serum Cr, CysC, and e-GFRMDRD, while it was not correlated with e-GFRC&G. In multivariate analysis, only CysC was significantly correlated with GFR (β, 45.620; 95% CI, 23.042-68.198; P<0.001). Serum CysC level was the only independent predictor for significant renal impairment.

Conclusions

Significant renal dysfunction was not rare in patients with cirrhotic ascites, even their serum Cr level is normal. Serum CysC is a useful marker for detecting significant renal dysfunction in these patients.

Citations

Citations to this article as recorded by  Crossref logo
  • Diagnostic value of serum TGF-β1 and CysC in type 2 diabetic kidney disease: a cross-sectional study
    Yi Kang, Qian Jin, Mengqi Zhou, Huijuan Zheng, Xiaobin Li, Aoshuang Li, Jing Wei Zhou, Jie Lv, Yaoxian Wang
    Frontiers in Medicine.2025;[Epub]     CrossRef
  • Zonula occludens 1 as a novel biomarker in decompensated alcoholic cirrhosis with hepatorenal syndrome
    Balasubramaniyan Vairappan, Raj Kumar, Mukta Wyawahare
    Exploration of Digestive Diseases.2025;[Epub]     CrossRef
  • Improved outcomes of kidney after liver transplantation after the implementation of the safety net policy
    Rose Mary Attieh, Ramez M. Ibrahim, Peter Ghali, Andrew Keaveny, Kristopher Croome, David Hodge, Launia White, Hani M. Wadei
    Liver Transplantation.2024; 30(6): 582.     CrossRef
  • The diagnostic and prognostic utility of serum cystatin C and angiopoietin 2 in patients with liver cirrhosis complicated by acute kidney injury
    Ahmed M. Abd El Wahab, Abeer Awadeen, Mostafa M. Mansour, Rasha Shemies
    Therapeutic Apheresis and Dialysis.2023; 27(3): 419.     CrossRef
  • Role of Novel Kidney Biomarkers in Patients With Cirrhosis and After Liver Transplantation
    Sumeet K. Asrani, Nagasri Shankar, Briget da Graca, Mitra K. Nadim, Andres Cardenas
    Liver Transplantation.2022; 28(3): 466.     CrossRef
  • Role of Serum Cystatin C as a Diagnostic Tool for Renal Function in Cirrhotic Patients
    Fathia Elsayed Asal, Mohamed Yousef, Hend Atteya Abdelkhalek Abdraboh, Sherief Abd-Elsalam, Ahmed Abdelaziz Abdelaziz Shama, Mohamed Elbahnasawy, Mohammed H Elnaggar, Hesham Ahmed Alsrogy, Heba Elashry
    The Open Biomarkers Journal.2022;[Epub]     CrossRef
  • Estimating Glomerular Filtration Rate in Cirrhosis Using Creatinine‐Based and Cystatin C–Based Equations: Systematic Review and Meta‐Analysis
    Prianka Singapura, Tsung‐Wei Ma, Naveed Sarmast, Stevan A. Gonzalez, François Durand, Rakhi Maiwall, Mitra K. Nadim, John Fullinwider, Giovanna Saracino, Claire Francoz, Rebecca Sartin, James F. Trotter, Sumeet K. Asrani
    Liver Transplantation.2021; 27(11): 1538.     CrossRef
  • Baseline serum cystatin C as a marker of acute kidney injury in patients with acute-on-chronic liver failure
    Praveen Jha, Ashish Kumar Jha, Vishwa Mohan Dayal, Sanjeev Kumar Jha, Amarendra Kumar
    Indian Journal of Gastroenterology.2021; 40(6): 563.     CrossRef
  • Serum cystatin C unmasks renal dysfunction in cirrhosis and performs better in estimation of glomerular filtration rate
    Balaraman Velayudham, RemiGeorge Thomas, C Vasudevan, RP Senthilkumar, Thirumalvalavan, Murugesan
    Saudi Journal of Kidney Diseases and Transplantation.2020; 31(6): 1320.     CrossRef
  • KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications

    Clinical and Molecular Hepatology.2018; 24(3): 230.     CrossRef
  • Role of Cystatin C and glomerular filtration rate in diagnosis of kidney impairment in hepatic cirrhosis patients
    Dong Wang, Jia-Fu Feng, An-Qun Wang, Yu-Wei Yang, Yun-Shuang Liu
    Medicine.2017; 96(20): e6949.     CrossRef
  • How to evaluate renal function in stable cirrhotic patients
    Florencia I. Aiello, Magdalena Bajo, Fernanda Marti, Carlos G. Musso
    Postgraduate Medicine.2017; 129(8): 866.     CrossRef
  • Appréciation du débit de filtration glomérulaire et de la dysfonction rénale chez le cirrhotique
    C. Mousseaux, A. Bouguerba, S. Ayed, J. Barchasz, M. Boukari, D. Goldgran-Toledano, C. Bornstain, F. Vincent
    Réanimation.2016; 25(S3): 137.     CrossRef
  • Evaluation of Serum Cystatin C as a Marker of Early Renal Impairment in Patients with Liver Cirrhosis
    Mahmoud Omar, Wael Abdel-Razek, Gamal Abo-Raia, Medhat Assem, Gasser El-Azab
    International Journal of Hepatology.2015; 2015: 1.     CrossRef
  • GFR Estimating Equations and Liver Disease
    Tomasz Beben, Dena E. Rifkin
    Advances in Chronic Kidney Disease.2015; 22(5): 337.     CrossRef
  • Prognostic value of serum cystatin C levels in cirrhotic patients with normal serum creatinine
    Bilyana Teneva, Emiliya Karaslavova
    Open Medicine.2014; 9(5): 625.     CrossRef
  • Update on Cystatin C: Incorporation Into Clinical Practice
    Michael G. Shlipak, Monica D. Mattes, Carmen A. Peralta
    American Journal of Kidney Diseases.2013; 62(3): 595.     CrossRef
  • Urine IL-18, NGAL, IL-8 and serum IL-8 are biomarkers of acute kidney injury following liver transplantation
    Jeffrey C Sirota, Angela Walcher, Sarah Faubel, Alkesh Jani, Kim McFann, Prasad Devarajan, Connie L Davis, Charles L Edelstein
    BMC Nephrology.2013;[Epub]     CrossRef
  • Impact of creatinine production on the agreement between glomerular filtration rate estimates using cystatin C-derived, and 4- and 6-variable Modification of Diet in Renal Disease (MDRD), and Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equ
    Esperanza F. Hermida-Cadahia, Natalia Lampon, J. Carlos Tutor
    Upsala Journal of Medical Sciences.2012; 117(4): 402.     CrossRef
  • Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury
    W. Stephen Waring, Alasdair Moonie
    Clinical Toxicology.2011; 49(8): 720.     CrossRef
  • 12,545 View
  • 89 Download
  • Crossref
Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis
Mi Yeon Chung, Dae Won Jun, Su Ah Sung
Korean J Hepatol 2010;16(3):301-307.
Published online September 30, 2010
DOI: https://doi.org/10.3350/kjhep.2010.16.3.301
Background/Aims

The present study aimed to determine the role of cystatin C as a prognostic factor for acute kidney injury and survival in cirrhotic patients.

Methods

The study investigated 53 liver cirrhosis patients. The renal function was evaluated by serum creatinine, serum and urine cystatin C, and 24-hour creatinine clearance on admission. Acute kidney injury was defined as a serum creatinine level exceeding the normal range (>1.2 mg/dl) and an increase of at least 50% from the baseline value. Multivariate analysis, receiver operating characteristic curve, and survival analysis were used to investigate prognostic factors for acute kidney injury and survival.

Results

Nine of the 53 cirrhotic patients (17.0%) developed acute kidney injury within 3 months. Both serum creatinine and cystatin C were predictive factors for acute kidney injury in univariate analysis, with a diagnostic accuracy of 0.735 (95% confidence interval (CI), 0.525-0.945; p=0.028) for serum cystatin C and 0.698 (95% CI, 0.495-0.901, p=0.063) for creatinine. In multivariate analysis, only serum cystatin C was an independent risk factor for acute kidney injury. The sensitivity and specificity of a serum cystatin C level of >1.23 mg/L to acute kidney injury were 66% and 86%, respectively. Serum cystatin C was positively correlated with the Model for End-Stage Liver Disease (MELD) and MELD-Na scores (r=0.346 and p=0.011, and r=0.427 and p=0.001, respectively). Comparison of the survival rates over the observation period revealed that a serum cystatin C level of >1.23 mg/L was a useful marker for short-term mortality (p<0.001).

Conclusions

The accuracy in predicting acute kidney injury and short-term mortality was higher for a serum cystatin C level of >1.23 mg/L than for the serum creatinine concentration in patients with cirrhosis.

Citations

Citations to this article as recorded by  Crossref logo
  • Nephroprotective potential of robinin to counteract aldicarb induced renal dysfunction via modulating TLR4/MyD88, HMGB1/RAGE, NF-κB pathway: A biochemical and pharmacodynamic approach
    Ning Li, Fuad M. Alzahrani, Mahmoud El Safadi, Sunbal Attaullah, Khalid J. Alzahrani, Faez Falah Alshehri, Arifa Mehreen, Tawaf Ali Shah
    Food and Chemical Toxicology.2025; 197: 115298.     CrossRef
  • Understanding acute kidney injury in cirrhosis: Current perspective
    Sayan Malakar, Sumit Rungta, Arghya Samanta, Umair Shamsul Hoda, Piyush Mishra, Gaurav Pande, Akash Roy, Suprabhat Giri, Praveer Rai, Samir Mohindra, Uday C Ghoshal
    World Journal of Hepatology.2025;[Epub]     CrossRef
  • Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis
    Adrià Juanola, Ann Thu Ma, Koos de Wit, Kohilan Gananandan, Olivier Roux, Giacomo Zaccherini, César Jiménez, Marta Tonon, Cristina Solé, Clara Villaseca, Frank E Uschner, Isabel Graupera, Elisa Pose, Maria José Moreta, Daniela Campion, Ulrich Beuers, Raje
    Gut.2024; 73(1): 156.     CrossRef
  • Predictive value of lipocalin 2 and cystatin C for acute kidney injury in patients with cirrhosis
    Xue-Qing Ma, Si-Si Yang, Huan-Qiu Wang, Jie Wu, Cheng-Bo Yu
    Hepatobiliary & Pancreatic Diseases International.2023; 22(1): 99.     CrossRef
  • Serum Cystatin C within 24 hours after admission: a potential predictor for acute kidney injury in Chinese patients with community acquired pneumonia
    Dawei Chen, Linglin Jiang, Yan Tan, Jing Zhao, Wenjuan Huang, Binbin Pan, Xin Wan
    Renal Failure.2023;[Epub]     CrossRef
  • Hepatorenal Syndrome—Novel Insights into Diagnostics and Treatment
    Krzysztof Badura, Weronika Frąk, Joanna Hajdys, Gabriela Majchrowicz, Ewelina Młynarska, Jacek Rysz, Beata Franczyk
    International Journal of Molecular Sciences.2023; 24(24): 17469.     CrossRef
  • Role of Serum Cystatin C as a Diagnostic Tool for Renal Function in Cirrhotic Patients
    Fathia Elsayed Asal, Mohamed Yousef, Hend Atteya Abdelkhalek Abdraboh, Sherief Abd-Elsalam, Ahmed Abdelaziz Abdelaziz Shama, Mohamed Elbahnasawy, Mohammed H Elnaggar, Hesham Ahmed Alsrogy, Heba Elashry
    The Open Biomarkers Journal.2022;[Epub]     CrossRef
  • Cystatin C in Patients with Acute Kidney Injury after Liver Transplantation
    晓蒙 杨
    Advances in Clinical Medicine.2021; 11(05): 2422.     CrossRef
  • Serum cystatin C as a predictor of 90‐day mortality among patients admitted with complications of cirrhosis
    Anuchit Suksamai, Amnart Chaiprasert, Sakkarin Chirapongsathorn
    JGH Open.2021; 5(5): 607.     CrossRef
  • Cystatin C: best biomarker for acute kidney injury and estimation of glomerular filtration rate in childhood cirrhosis
    Priti Vijay, Bikrant Bihari Lal, Vikrant Sood, Rajeev Khanna, Seema Alam
    European Journal of Pediatrics.2021; 180(11): 3287.     CrossRef
  • Baseline serum cystatin C as a marker of acute kidney injury in patients with acute-on-chronic liver failure
    Praveen Jha, Ashish Kumar Jha, Vishwa Mohan Dayal, Sanjeev Kumar Jha, Amarendra Kumar
    Indian Journal of Gastroenterology.2021; 40(6): 563.     CrossRef
  • Acute kidney injury in children with chronic liver disease
    Akash Deep, Romit Saxena, Bipin Jose
    Pediatric Nephrology.2019; 34(1): 45.     CrossRef
  • Cystatin C predicts acute kidney injury and mortality in cirrhotics: A prospective cohort study
    Rakhi Maiwall, Awinash Kumar, Ankit Bhardwaj, Guresh Kumar, Ajeet S. Bhadoria, Shiv K. Sarin
    Liver International.2018; 38(4): 654.     CrossRef
  • Value of urinary KIM-1 and NGAL combined with serum Cys C for predicting acute kidney injury secondary to decompensated cirrhosis
    Lei Lei, Liang Ping Li, Zhen Zeng, Jing Xi Mu, Xue Yang, Chao Zhou, Zhi Lan Wang, Hu Zhang
    Scientific Reports.2018;[Epub]     CrossRef
  • Can admission serum cystatin C level be an early marker subclinical acute kidney injury in critical care patients?
    Ümmügülsüm Gaygısız, Müge Aydoğdu, Melike Badoğlu, Nazlıhan Boyacı, Zuhal Güllü, Gül Gürsel
    Scandinavian Journal of Clinical and Laboratory Investigation.2016; 76(2): 143.     CrossRef
  • Prognostic value of serum cystatin C levels in cirrhotic patients with normal serum creatinine
    Bilyana Teneva, Emiliya Karaslavova
    Open Medicine.2014; 9(5): 625.     CrossRef
  • Impact of Birth Cohort Screening for Hepatitis C
    Sumeet K. Asrani, Gary L. Davis
    Current Gastroenterology Reports.2014;[Epub]     CrossRef
  • Early Trends in Cystatin C and Outcomes in Patients with Cirrhosis and Acute Kidney Injury
    Justin M. Belcher, Arun J. Sanyal, Guadalupe Garcia-Tsao, Naheed Ansari, Steven G. Coca, Michael G. Shlipak, Chirag R. Parikh
    International Journal of Nephrology.2014; 2014: 1.     CrossRef
  • The impacts of thyroid function on the diagnostic accuracy of Cystatin C to detect acute kidney injury in ICU patients: a prospective, observational study
    Feilong Wang, Wenzhi Pan, Hairong Wang, Yu Zhou, Shuyun Wang, Shuming Pan
    Critical Care.2014;[Epub]     CrossRef
  • Serum cystatin C level is a useful marker for the evaluation of renal function in patients with cirrhotic ascites and normal serum creatinine levels
    Dong Jin Kim, Hyun Seok Kang, Hyuk Soon Choi, Hye Jin Cho, Eun Sun Kim, Bora Keum, Hyonggin An, Ji Hoon Kim, Yeon Seok Seo, Yong Sik Kim, Hyung Joon Yim, Yoon Tae Jeen, Hong Sik Lee, Soon Ho Um, Chang Duck Kim, Ho Sang Ryu
    The Korean Journal of Hepatology.2011; 17(2): 130.     CrossRef
  • Cystatin C in Prediction of Acute Kidney Injury: A Systemic Review and Meta-analysis
    Zhongheng Zhang, Baolong Lu, Xiaoyan Sheng, Ni Jin
    American Journal of Kidney Diseases.2011; 58(3): 356.     CrossRef
  • 12,692 View
  • 80 Download
  • Crossref